the canadian american ticlopidine study is a randomized , placebo-controlled , double-blind , multicenter study to assess the efficacy and safety of ticlopidine hydrochloride in patients who have suffered a thromboembolic stroke no less than 1 week and no more than 4 months before entry into the study .
C0000598
ticlopidine
C0038454
stroke